Skip to Main Content

Paper Details

Author Correction: Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia.
Nat Med
9
2021
CAR, CD19, T cell, chimeric antigen receptor, chronic lymphocytic leukemia
Author NameAffiliation
Hans BitterNovartis Institutes for BioMedical Research
Carl H JuneUniversity of Pennsylvania
Carl H JuneCenter for Cellular Immunotherapies, University of Pennsylvania
Carl H JuneParker Institute for Cancer Immunotherapy at University of Pennsylvania
  • 1 - 4

Datasets

Release 1.2